Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Bekhite MM et al. | 2010 | intact cell/cell culture, embryonic stem cells, animal, mouse/Balb/c (embryos) | static magnetic field, DC | 0.4–10 mT |
| Nadeev AD et al. | 2018 | intact cell/cell culture, erythrocytes (Wistar rat) | geomagnetic field, shielding/field deprivation | - |
| Doltchinkova V et al. | 2023 | intact cell/cell culture, erythrocytes (healthy human and patientes with β-thalassemia) | static magnetic field | - |
| Kula B et al. | 1996 | intact cell/cell culture, fibroblasts | magnetic field, static magnetic field, low frequency, 50/60 Hz | 20–490 mT |
| Kurzeja E et al. | 2013 | intact cell/cell culture, fibroblasts | static magnetic field, co-exposure | 0.4–0.7 T |
| Wang D et al. | 2018 | intact cell/cell culture, human cancer cell lines (HeLa, HCT116, MCF7, A549, and GIST-T1), rat cancer cell lines (differentiated PC12, undifferentiated PC12, and C6), non-cancer cell lines (RPE1, CHO, and 293T) | 50/60 Hz, static magnetic field, magnetic field | - |
| Pawlowska-Goral K et al. | 2016 | intact cell/cell culture, human dermal fibroblasts | static magnetic field, co-exposure | 0.4–0.7 mT |
| Kimsa-Dudek M et al. | 2018 | intact cell/cell culture, human dermal fibroblasts | static magnetic field, co-exposure | - |
| Doltcthinkova V et al. | 2009 | intact cell/cell culture, human erythrocytes | static magnetic field | 0.1–2 T |
| Chen HX et al. | 2024 | intact cell/cell culture, human hepatocarcinoma cell line (HepG2), animal, C57BL/6J mouse | static magnetic field | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
